Angioflux, 600 units, 2 ml, 10 pcs.

An anticoagulant agent, heparinoid. It has antiaggregant, antithrombotic, angioprotective, hypolipidemic and fibrinolytic effect. The active substance is an extract from the mucous membrane of small intestine of animals and is a natural mixture of fast-moving heparin-like fraction (80%) and dermatan-sulfate (20%).

Suppresses activated factor X, increases the synthesis and secretion of prostacyclin (prostaglandin PgI2), reduces the concentration of plasma fibrinogen. Increases the concentration of the activator of tissue profibrinolysin (plasminogen) in blood and decreases the blood concentration of its inhibitor.

The mechanism of angioprotective action is associated with restoration of structural and functional integrity of vascular endothelial cells, as well as the normal density of the negative electric charge of pores of the basal membrane of vessels. Normalizes rheological properties of blood by reducing TG and decreasing blood viscosity.

The efficacy of use in diabetic nephropathy is determined by reduction of basal membrane thickness and decrease of matrix production due to decrease of mesangium cell proliferation.

Indications

Angiopathy with an increased risk of thrombosis, including:
After a myocardial infarction.
Cerebral circulatory disorders, including the acute period of ischemic stroke and the period of early recovery.
Discirculatory encephalopathy caused by:
Atherosclerosis.
Diabetes mellitus.
Arterial hypertension.
Vascular dementia.
Occlusive lesions of peripheral arteries, including:
Atherosclerotic origin.
Diabetic origin.
Phlebopathy, deep vein thrombosis.
Microangiopathies:
Nephropathy.
Retinopathy.
Neuropathy.
Macroangiopathy in diabetes mellitus:
Diabetic foot syndrome.
Encephalopathy.
Cardiopathy.
As part of combination therapy with acetylsalicylic acid:
Thrombotic conditions.
Antiphospholipid syndrome.
To continue therapy with the development of heparin-induced thrombotic thrombocytopenia.

Pharmacological effect

Anticoagulant agent, heparinoid. It has antiplatelet, antithrombotic, angioprotective, hypolipidemic and fibrinolytic effects. The active substance – an extract from the mucous membrane of the small intestine of animals, is a natural mixture of fast-moving heparin-like fraction (80%) and dermatan sulfate (20%).

Suppresses activated factor X, enhances the synthesis and secretion of prostacyclin (prostaglandin PgI2), reduces the concentration of fibrinogen in plasma. Increases the concentration of tissue profibrinolysin activator (plasminogen) in the blood and reduces the concentration of its inhibitor in the blood.

The mechanism of angioprotective action is associated with the restoration of the structural and functional integrity of vascular endothelial cells, as well as the normal density of the negative electrical charge of the pores of the vascular basement membrane. Normalizes the rheological properties of blood by reducing TG and reducing blood viscosity.

The effectiveness of use in diabetic nephropathy is determined by a decrease in the thickness of the basement membrane and a decrease in matrix production due to a decrease in the proliferation of mesangium cells.

Special instructions

Before starting treatment, a coagulogram should be done. Use with caution during pregnancy and breastfeeding (safety and effectiveness have not been determined).

Active ingredient

Sulodexide

Composition

Active ingredient:

sulodexide 300 units.

Contraindications

Hemorrhagic diathesis and other diseases accompanied by decreased blood clotting.
Hypersensitivity to sulodexide or any other components included in the drug.
Pregnancy.
Lactation period.
Children’s age (due to lack of clinical experience).

Side Effects

Dyspeptic symptoms (including nausea, vomiting), epigastric pain, allergic reactions; at the injection site – pain, burning, hematoma.

Interaction

Simultaneous use with drugs that affect the hemostatic system (direct and indirect anticoagulants, antiplatelet agents) is not recommended.

Overdose

Symptoms: Bleeding or bleeding.

Treatment: maintenance of vital functions (during drug withdrawal).

Storage conditions

The drug should be stored at a temperature not exceeding 30°C.

Shelf life

3 years.

Manufacturer

Mitim, Italy